16.3% of UK Dental Staff Test Positive for SARS-CoV-2 Antibodies

Dentistry Today


A study led by the University of Birmingham of more than a thousand dental professionals has shown their increased occupational risk of SARS-CoV-2 infection during the first wave of the pandemic in the United Kingdom.

The observational cohort study involved 1,507 Midland dental care practitioners. Blood samples were taken from the cohort at the start of the study in June 2020 to measure their levels of antibodies against SARS-CoV-2.

The researchers found that 16.3% of study participants including dentists, dental nurses, and dental hygienists had SARS-CoV-2 antibodies, compared to 6% of the general population at the time.

Meanwhile, the percentage of dental practice receptionists, who have no direct patient contact, with SARS-CoV-2 antibodies was comparable to the general population, supporting the hypothesis that occupational risk arose from close exposure to patients.

Ethnicity also was a significant risk factor for infection, with 35% of Black participants and 18.8% of Asian participants having SARS-CoV-2 antibodies, compared to 14.3% of White participants.

Blood samples were taken from participants three months later, in September 2020, when dental practices in England had reopened with enhanced PPE and infection control measures in place and once again in January 2021, six months after the start of the study, during the second wave of the pandemic when healthcare workers were being vaccinated.

Of those who had previous COVID-19 infection, more than 70% continued to have SARS-CoV-2 antibodies both at three months and six months later, and they were at a 75% reduced risk of re-infection with the virus.

The study also demonstrated the immunological impact of COVID-19 vaccination, the researchers said, with 97.7% of those without previous infection developing an antibody response at least 12 days after their first Pfizer vaccine. In those with evidence of previous infection, the antibody response was more rapid and higher in magnitude after a single dose of the Pfizer vaccine.

Furthermore, none of the cohort with a level of SARS-CoV-2 antibodies greater than 147.6 IU/ml in their blood tested positive for COVID-19 throughout the six-month period from the first to the final blood tests.

“Understanding what an antibody test result means to an individual with respect to their risk of infection is essential to controlling the pandemic,” said first author Dr. Adrian Shields of the University of Birmingham’s Institute of Immunology and Immunotherapy.

“Our study has taken the first steps in defining the level of antibody in a persons’ blood necessary to protect them from infection for six months,” said Shields.

“Furthermore, by comparing the antibody levels we have found in dentists to those contained in widely available reference material produced by the World Health Organization, we hope the protective level we found can be easily confirmed and compared by other laboratories,” Shields said.

“Critically, only 5.3% of the cohort developed an antibody response that exceeded this threshold of 147.6 IU/ml following the first wave of the UK pandemic,” said corresponding author Thomas Dietrich of the University of Birmingham School of Dentistry.

“This suggests that natural infection alone is unlikely to generate meaningful, durable herd immunity,” Dietrich said.

“Dental professionals are thought to be at high risk of exposure to SARS-CoV-2 because they routinely operate within patients’ aerodigestive tract and regularly carry out aerosol-generating procedures that result in the production of airborne particles,” said corresponding author Iain Chapple, professor of periodontology at the University of Birmingham.

“Through our research, we have clearly shown that dental professionals were at increased occupational risk of exposure to SARS-CoV-2 prior to the new PHE guidance on PPE,” said Chapple, who also is a consultant in restorative dentistry at Birmingham Community Healthcare Trust.

“The occupational health measures that have been put in place in general dental practice as a consequence of COVID-19 appear to remove that increased risk. However, this will need to be thoroughly investigated to see if they have successfully interrupted transmission of SARS-CoV-2 and other respiratory viruses,” said Chapple.

“This is the first time the occupational risk of exposure to a potentially fatal respiratory virus has been studied in a large dental cohort,” said co-corresponding author Alex Richter, also of the University of Birmingham.

“It is important that we now progress our research to ensure we have an understanding of how people are protected from re-infection with COVID-19 following natural infection and vaccination,” said Richter.

“The nature and duration of immunity in these cohorts will be critical to understand as the COVID-19 pandemic progresses, particularly with respect to the efficacy of vaccination strategies—single-dose, multiple doses, vaccine combinations—and in relation to novel viral variants of concern,” said Richter.

The study, “COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals,” was published by the Journal of Dental Research.

Related Articles

US Dentists See at 2.6% COVID-19 Infection Rate

Pandemic Prompts 23% of Physicians to Consider Leaving the Profession

26% of Dental Staff in Scottish Study Have Been Infected With COVID-19